Guangzhou Xiangxue Pharmaceutical Co.,Ltd. Posted 153.4 Million Yuan Net Loss in First Half of 2022

Guangzhou Xiangxue Pharmaceutical Co.,Ltd. (广州市香雪制药股份有限公司) (300147.SZ) reported a net loss of 153.4 million yuan in the first half of 2022, reversing a net profit of 72.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 22.4% year-on-year.

At the end of the reporting period, it had 10.9 billion yuan in total assets and 7.3 billion yuan in total liabilities, with a liability-to-asset ratio of 66.6%.